BioPharm International, May 2012 - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

BioPharm International, May 2012
Features
Development of an Alternative Monoclonal Antibody Polishing Step
By Yun (Kenneth) Kang , Stanley Ng , Julia Lee , Josaih Adaelu , Bo Qi , Kris Persaud , Dale Ludwig , Paul Balderes
MAb polishing using salt tolerant interaction membrane chromatography.
Oxidative Folding of Proteins in Escherichia Coli
By Mehmet Berkmen
The author highlights novel strains and methods that have recently been shown to express multidisulfide bonded proteins.
Consistent Production of Genetically Stable Mammalian Cell Lines
By Gregory T. Bleck
The author describes expression technology that produces cell lines with high genetic stability.
Applying Quality by Design to Lyophilization
By Stephanie Sutton
Featuring expert insights from GSK Biologicals, Baxter Pharmaceutical Solutions, GEA Pharma Systems, and more.
Optimizing Drug Delivery for Modern Biologics
By Bart E. Burgess
This article discusses potential opportunities to improve the patient experience through formulation and delivery device technologies.
Choosing an Expression System
By Amy Ritter, PhD
A Q&A with Alan Shaw of Vaxinnate. This article is part of a special section on expression systems.
A 25-Year Retrospective on the Biotech Business
This month, we rewind to an article titled "The Biotechnology Industry: A First Quarter Snapshot."
From the Editor
Some Supply Chain Lessons Can Go a Long Way
By Angie Drakulich
No matter the time or cost, knowing what's going on inside your facilities is always going to be worth the effort.
Regulatory Beat
FDA Explores Options to Expand Access to NonPrescription Drugs
By Jill Wechsler
Manufacturers seek clear path to develop safe-use approaches for more risky OTC therapies.
Perspectives on Outsourcing
Channeling Steve Jobs
By Jim Miller
Service providers must focus on delivering a superior customer experience.
Compliance Notes
How to Respond to Consent Decrees
By David L. Rosen
How to handle and respond to a consent decree.
Boot Camp Business Guide
Changing Your Business Model
By Tarja Mottram
BioPharm talks with Tarja Mottram, CEO of Action for Results, on design-for-value concepts, management, and cross-functionality.
Final Word
A New Way to Think About Outsourcing Partnerships
By Nancy Gillett
Future sponsor-contract provider relationships will require more integration.

ADVERTISEMENT

ADVERTISEMENT

Click here